Engrail Therapeutics Inc
Clinical trials sponsored by Engrail Therapeutics Inc, explained in plain language.
-
New drug tested for Hard-to-Treat depression symptom
Disease control CompletedThis study tested a new drug called ENX-104 in people with major depression who also experience anhedonia, which is a loss of interest or pleasure. The main goal was to see if the drug was safe and how the body processes it. The study involved 48 participants and was an early-sta…
Phase: PHASE1 • Sponsor: Engrail Therapeutics INC • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
New anxiety drug tested for safety and dose
Disease control CompletedThis study tested a new medication called ENX-102 for people with Generalized Anxiety Disorder (GAD). The main goals were to check if the drug was safe and to find the best dose. Thirty-eight adults with GAD participated, and some received the drug while others received a placebo…
Phase: PHASE2 • Sponsor: Engrail Therapeutics INC • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New anxiety drug shows promise in clinical trial
Symptom relief CompletedThis completed study tested whether a new medication called ENX-102 helps reduce symptoms of generalized anxiety disorder. Researchers compared ENX-102 against a placebo pill in 252 adults with moderate-to-severe anxiety. The main goal was to see if the drug safely reduced anxiet…
Phase: PHASE2 • Sponsor: Engrail Therapeutics INC • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC
-
First look at new brain drug in healthy people
Knowledge-focused CompletedThis early-stage study tested a single oral dose of a new drug called ENX-104 in 10 healthy volunteers. The main goals were to see if it was safe, how it moved through the body, and how much it attached to specific targets in the brain using PET scans. This type of study helps re…
Phase: PHASE1 • Sponsor: Engrail Therapeutics INC • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC